Abstract:Purpose High‐quality CBCT and AI‐enhanced adaptive planning techniques allow CBCT‐guided stereotactic adaptive radiotherapy (CT‐STAR) to account for inter‐fractional anatomic changes. Studies of intra‐fractional respiratory motion management with a surface imaging solution for CT‐STAR have not been fully conducted. We investigated intra‐fractional motion management in breath‐hold Ethos‐based CT‐STAR and CT‐SBRT (stereotactic body non‐adaptive radiotherapy) using optical surface imaging combined with onboard CBCTs. Methods Ten cancer patients with mobile lower lung or upper abdominal malignancies participated in an IRB‐approved clinical trial (Phase I) of optical surface image‐guided Ethos CT‐STAR/SBRT. In the clinical trial, a pre‐configured gating window (± 2 mm in AP direction) on optical surface imaging was used for manually triggering intra‐fractional CBCT acquisition and treatment beam irradiation during breath‐hold (seven patients for the end of exhalation and three patients for the end of inhalation). Two inter‐fractional CBCTs at the ends of exhalation and inhalation in each fraction were acquired to verify the primary direction and range of the tumor/imaging‐surrogate (donut‐shaped fiducial) motion. Intra‐fractional CBCTs were used to quantify the residual motion of the tumor/imaging‐surrogate within the pre‐configured breath‐hold window in the AP direction. Fifty fractions of Ethos RT were delivered under surface image‐guidance: Thirty‐two fractions with CT‐STAR (adaptive RT) and 18 fractions with CT‐SBRT (non‐adaptive RT). The residual motion of the tumor was quantified by determining variations in the tumor centroid position. The dosimetric impact on target coverage was calculated based on the residual motion. Results We used 46 fractions for the analysis of intra‐fractional residual motion and 43 fractions for the inter‐fractional motion analysis due to study constraints. Using the image registration method, 43 pairs of inter‐fractional CBCTs and 100 intra‐fractional CBCTs attached to dose maps were analyzed. In the motion range study (image registration) from the inter‐fractional CBCTs, the primary motion (mean ± std) was 16.6 ± 9.2 mm in the SI direction (magnitude: 26.4 ± 11.3 mm) for the tumors and 15.5 ± 7.3 mm in the AP direction (magnitude: 20.4 ± 7.0 mm) for the imaging‐surrogate, respectively. The residual motion of the tumor (image registration) from intra‐fractional breath‐hold CBCTs was 2.2 ± 2.0 mm for SI, 1.4 ± 1.4 mm for RL, and 1.3 ± 1.3 mm for AP directions (magnitude: 3.5 ± 2.1 mm). The ratio of the actual dose coverage to 99%, 90%, and 50% of the target volume decreased by 0.95 ± 0.11, 0.96 ± 0.10, 0.99 ± 0.05, respectively. The mean percentage of the target volume covered by the prescribed dose decreased by 2.8 ± 4.4%. Conclusion We demonstrated the intra‐fractional motion‐managed treatment strategy in breath‐hold Ethos CT‐STAR/SBRT using optical surface imaging and CBCT. While the controlled residual tumor motion measured at 3.5 mm exceeded the predetermined setup value of 2 mm, it is important to note that this motion still fell within the clinically acceptable range defined by the PTV margin of 5 mm. Nonetheless, additional caution is needed with intra‐fractional motion management in breath‐hold Ethos CT‐STAR/SBRT using optical surface imaging and CBCT.

An Evaluation of Total Internal Motions of Locally Advanced Pancreatic Cancer during SABR Using Calypso® Extracranial Tracking, and Its Possible Clinical Impact on Motion Management

Stereotactic Ablative Radiotherapy Using CALYPSO® Extracranial Tracking for Intrafractional Tumor Motion Management—A New Potential Local Treatment for Unresectable Locally Advanced Pancreatic Cancer? Results from a Retrospective Study

Adaptive motion mapping in pancreatic SBRT patients using Fourier transforms

Evaluation of Inter- and Intra-Fractional Pancreas Tumor Residual Motions with Abdominal Compression

Assessment of fiducial motion in CBCT projections of the abdominal tumor using template matching and sequential stereo triangulation

Study on Motion Management of Pancreatic Cancer Treated by CyberKnife

Clinical experience with adaptive MRI-guided pancreatic SBRT and the use of abdominal compression to reduce treatment volume

Abdominal and Pancreatic Motion Correlation Using 4D CT, 4D Transponders, and a Gating Belt.

Real-time intra-fraction motion management in breast cancer radiotherapy: analysis of 2028 treatment sessions

SU‐D‐18A‐07: Towards 6‐degree‐of‐freedom Real‐Time Motion Management in Cancer Radiotherapy

Intra-fractional lung tumor motion monitoring using arbitrary gantry angles during radiotherapy treatment

Feasibility of surface‐guidance combined with CBCT for intra‐fractional breath‐hold motion management during Ethos RT

Analysis of sagittal plane cine magnetic resonance imaging for measurement of pancreatic tumor residual motion during breath hold and evaluation of gating margins used in radiotherapy treatment

Toward submillimeter accuracy in the management of intrafraction motion: the integration of real-time internal position monitoring and multileaf collimator target tracking

Novel utilization and quantification of Xsight diaphragm tracking for respiratory motion compensation in Cyberknife Synchrony treatment of liver tumors

Simultaneous Motion Monitoring and Truth-In-Delivery Analysis Imaging Framework for MR-guided Radiotherapy

Liver-ultrasound-guided lung tumour tracking for scanned proton therapy: a feasibility study

Quantification of Intrafraction and Interfraction Tumor Motion Amplitude and Prediction Error for Different Liver Tumor Trajectories in Cyberknife Synchrony Tracking

SU‐E‐J‐10: Inter‐Fractional Tumor Motion Analysis Using 4D‐CT and CBCT

Accuracy of four models and update strategies to estimate liver tumor motion from external respiratory motion

Toward quantitative intrafractional monitoring in paraspinal SBRT using a proprietary software application: clinical implementation and patient results